S433 300 mg (Carbamazepine extended-release 300 mg)
Pill imprint S433 300 mg has been identified as Carbamazepine extended-release 300 mg.
Carbamazepine is used in the treatment of bipolar disorder; trigeminal neuralgia; schizoaffective disorder; epilepsy; borderline personality disorder (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- S433 300 mg
- Strength:
- 300 mg
- Color:
- Black / Green
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Dibenzazepine anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Prasco Laboratories
- National Drug Code (NDC):
- 66993-0409
- Inactive Ingredients:
- citric acid monohydrate
silicon dioxide
lactose monohydrate
microcrystalline cellulose
polyethylene glycol
povidone
sodium lauryl sulfate
magnesium silicate
triethyl citrate
gelatin
FD&C Blue No. 2
FD&C Yellow No. 6
ferric oxide red
ferric oxide yellow
titanium dioxide
More about carbamazepine
Consumer resources
- Carbamazepine
- Carbamazepine chewable tablets
- Carbamazepine suspension
- Carbamazepine sustained-release capsules
- Carbamazepine sustained-release tablets
- Carbamazepine (Advanced Reading)
- Other brands: Tegretol, Carbatrol, Epitol, Tegretol XR, More (1) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
